Cohort Evaluated | Incremental Life Years |
---|---|
PMO Patients (100% Female), age 69 years, T-Score = −3.0 | |
historical vertebral + incident vertebral fracture | |
Teriparatide vs. No Treatment | 132 |
Teriparatide vs. bisphosphonate | 102 |
incident vertebral fracture | |
Teriparatide vs. No Treatment | 102 |
Teriparatide vs. bisphosphonate | 77 |
GIOP Patients (80% Female), age 69 years, T-Score = −2.5 | |
historical vertebral + incident vertebral fracture | |
Teriparatide vs. No Treatment | 153 |
Teriparatide vs. bisphosphonate | 117 |
incident vertebral fracture | |
Teriparatide vs. No Treatment | 140 |
Teriparatide vs. bisphosphonate | 106 |